Skip Navigation LinksHome > Current Issue > Contributor Index

February 2015 - Volume 25 - Issue 2 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 9 Next
Author Name Article
Alexander, Vinita M. MD

Increased Notch1 Expression Is Associated With Poor Overall Survival in Patients With Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
AlHilli, Mariam MBBCh

Risk Factors and Indications for 30-Day Readmission After Primary Surgery for Epithelial Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Alniaimi, Ahmed Numan MD

Increased Notch1 Expression Is Associated With Poor Overall Survival in Patients With Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Angioli, Roberto MD

Management of Bilateral Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bakkum-Gamez, Jamie MD

Risk Factors and Indications for 30-Day Readmission After Primary Surgery for Epithelial Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Balleyguier, Corinne MD

Multimodal Treatment With Doxorubicin, Cisplatin, and Ifosfamide for the Treatment of Advanced or Metastatic Uterine Leiomyosarcoma: A Unicentric Experience

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Beller, Uziel MD

Editorial

Purchase Access
PDF
+ Favorites
Request Permissions
Bentivegna, Enrica MD

Gliomatosis Peritonei: A Particular Entity With Specific Outcomes Within the Growing Teratoma Syndrome

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Blaakaer, Jan DMSC

Addressing Challenges in Future Surveillance After Surgery for Early-Stage Cervical Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bogani, Giorgio MD

Chemotherapy Reduces Para-aortic Node Recurrences in Endometrial Cancer With Positive Pelvic and Unknown Para-aortic Nodes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bogner, Gerhard MD

Carboplatin and Nonpegylated Liposomal Doxorubicin in Primary Advanced or Recurrent Endometrial Cancer: A Phase 2 Trial Conducted by AGO Austria

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boraska Jelavic, Tihana MD, PhD

Long Follow-up of Patients With Locally Advanced Cervical Cancer Treated With Concomitant Chemobrachyradiotherapy With Cisplatin and Ifosfamide Followed by Consolidation...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bruixola, Gema MD

Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Caballero, Javier MD

Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Caltová, Katerina BSc, PhD

Clinical Significance of the Resistance Proteins LRP, Pgp, MRP1, MRP3, and MRP5 in Epithelial Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Candiani, Massimo MD

Management of Bilateral Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Casarin, Jvan MD

Chemotherapy Reduces Para-aortic Node Recurrences in Endometrial Cancer With Positive Pelvic and Unknown Para-aortic Nodes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cella, David PhD

Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologic Oncology...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cervinka, Miroslav MD, PhD

Clinical Significance of the Resistance Proteins LRP, Pgp, MRP1, MRP3, and MRP5 in Epithelial Ovarian Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chase, Dana M. MD

Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologic Oncology...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 9 Next